Zhe Jiang Dayang Biotech Group Balance Sheet Health
Financial Health criteria checks 5/6
Zhe Jiang Dayang Biotech Group has a total shareholder equity of CN¥1.0B and total debt of CN¥338.6M, which brings its debt-to-equity ratio to 32.9%. Its total assets and total liabilities are CN¥1.6B and CN¥584.3M respectively. Zhe Jiang Dayang Biotech Group's EBIT is CN¥74.6M making its interest coverage ratio -132.8. It has cash and short-term investments of CN¥377.8M.
Key information
32.9%
Debt to equity ratio
CN¥338.57m
Debt
| Interest coverage ratio | -132.8x |
| Cash | CN¥377.82m |
| Equity | CN¥1.03b |
| Total liabilities | CN¥584.35m |
| Total assets | CN¥1.61b |
Financial Position Analysis
Short Term Liabilities: 003017's short term assets (CN¥667.1M) exceed its short term liabilities (CN¥549.8M).
Long Term Liabilities: 003017's short term assets (CN¥667.1M) exceed its long term liabilities (CN¥34.5M).
Debt to Equity History and Analysis
Debt Level: 003017 has more cash than its total debt.
Reducing Debt: 003017's debt to equity ratio has increased from 6.4% to 32.9% over the past 5 years.
Debt Coverage: 003017's debt is well covered by operating cash flow (48.8%).
Interest Coverage: 003017 earns more interest than it pays, so coverage of interest payments is not a concern.